Fatal Pseudomona pneumonia following rituximab therapy in a patient with epidermolysis bullosa acquisita.
Mercader
P
P
Rodenas
J M
JM
Peña
A
A
Mascaro
J M
JM
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000009:adverse effects*; D016107:Epidermolysis Bullosa Acquisita / Q000188:drug therapy*; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D018410:Pneumonia, Bacterial / Q000139:chemically induced*; D011552:Pseudomonas Infections / Q000139:chemically induced*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab